Every Alternative to Wellorithm
Wellorithm charges $247 a month for semaglutide and tirzepatide. 1 of the 12 sellers compared here cost less, led by Eden at $239 ($8 a month less). All 12 score higher than Wellorithm's 5.9/10, and TMates rates highest at 7.6.
Baseline for every row below
Wellorithm advertises $147 for month one. Every row below compares against the standing $247/mo you pay from month two, not the introductory rate.
Editor's picks
Top alternatives to Wellorithm
No insurance needed
vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
- Top pickGet started →Save $8/mo
From
$239/mo
- 6.7Get started →
From
$249/mo
- 6.6Get started →
From
$249/mo
- Get started →
From
$249/mo
| Provider | From | Save vs Wellorithm | |
|---|---|---|---|
6.7EdenTop pick | $239/mo | Save $8/mo | Get started → |
6.7RxSpan MD | $249/mo | — | Get started → |
6.6Luvo Health | $249/mo | — | Get started → |
6.4Direct Meds | $249/mo | — | Get started → |
How Wellorithm compares on the four things that matter
- Monthly price. Wellorithm: $247 a month. Cheaper here: Eden ($239). The table compares standing monthly rates, not first-month promotions.
- Medication. Wellorithm sells compounded semaglutide and tirzepatide. For FDA-approved brand-name pens, RxSpan MD, Luvo Health and MEDVi sell them. If you would rather not inject, Luvo Health, Direct Meds and MEDVi offer an oral option.
- Where it ships. Wellorithm says it serves all 50 states, so coverage is not a reason to switch.
- What the price includes. Wellorithm does not say what its price includes.
The rest of the category
Everything else we track in this category, and how each one prices against Wellorithm.
- TMatesCoaching inside the $249/month rather than sold separately$249/mo7.6/10No monthly saving to showGo to site
- Independent WellnessBloodwork inside the monthly price rather than billed on top$249/mo7.4/10No monthly saving to showGo to site
- Peak WellnessCoverage in all 50 states, which most sellers will not confirm$249/mo7.4/10No monthly saving to showGo to site
- MEDViKnowing which pharmacy fills the vial: it names Triad Rx$249/mo7.1/10No monthly saving to showGo to site
- Bloom MDStarting below a standard dose, with microdose tiers$245/mo7.0/10Costs $2/mo less than WellorithmGo to site
- NoluAn oral route if you will not self-inject$249/mo6.6/10No monthly saving to showGo to site
- NuDay RxCompounded semaglutide at $249/month$249/mo6.6/10No monthly saving to showGo to site
- RX BellaFlat-rate compounded GLP-1 care, if you can accept an unnamed pharmacy and medical group$249/mo6.6/10No monthly saving to showGo to site
| Seller | Score | From | vs Wellorithm | Site |
|---|---|---|---|---|
| TMatesCoaching inside the $249/month rather than sold separately | 7.6/10 | $249/mo | — | Go to site |
| Independent WellnessBloodwork inside the monthly price rather than billed on top | 7.4/10 | $249/mo | — | Go to site |
| Peak WellnessCoverage in all 50 states, which most sellers will not confirm | 7.4/10 | $249/mo | — | Go to site |
| MEDViKnowing which pharmacy fills the vial: it names Triad Rx | 7.1/10 | $249/mo | — | Go to site |
| Bloom MDStarting below a standard dose, with microdose tiers | 7.0/10 | $245/mo | Costs $2/mo less | Go to site |
| NoluAn oral route if you will not self-inject | 6.6/10 | $249/mo | — | Go to site |
| NuDay RxCompounded semaglutide at $249/month | 6.6/10 | $249/mo | — | Go to site |
| RX BellaFlat-rate compounded GLP-1 care, if you can accept an unnamed pharmacy and medical group | 6.6/10 | $249/mo | — | Go to site |
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory